The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland-Reference-Cited by-同舟云学术

The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland

Published:2022-08 Issue: Volume:190 Page:110023
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Bogdanet Delia^ORCID,Toth Castillo Michelle,Doheny Helen,Dervan Louise,Angel Luque-Fernandez Miguel,Halperin Jose,O'Shea Paula M.,Dunne Fidelma P.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference14 articles.

1. Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence?;Raets;J Clin Med,2021

2. Hyperglycaemia in early pregnancy: the Treatment of Booking Gestational diabetes Mellitus (TOBOGM) study. A randomised controlled trial;Simmons;Med J Aust,2018

3. Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop;Wexler;Obstet Gynecol,2018

4. Membrane defence against complement lysis: the structure and biological properties of CD59;Davies;Immunol Res,1993

5. A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetes;Ghosh;Am J Hematol,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of Gestational Diabetes Mellitus across Continents in 21st Century;International Journal of Environmental Research and Public Health;2022-11-28